Purpose To develop a novel cancer vaccine using the targeting system of antigen protein to
antigen-presenting cells (APCs) for efficient and safe cancer therapy. Methods The novel …

Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-
associated antigens are excellent targets for immune therapy and vaccine design. Optimally …

Cancer immunotherapy has branched into various categories, and one of the most
promising and also frustrating approaches is cancer vaccination. Vaccination has saved a …

Purpose The clinical efficacy of cancer peptide vaccine therapy is insufficient. To enhance
the anti-tumor effect of peptide vaccine therapy, we combined this therapy with an anti-CD4 …

Recent progress in fundamental understanding of tumor immunology has opened a new
avenue of cancer vaccines. Currently, the development of new cancer vaccines is a global …

Therapeutic cancer vaccines have enjoyed little success so far, although many clinical trials
have been conducted. Therefore, the creation of new protocols capable of inducing an …

Melanoma cells are significantly resistance to the current treatments. Therefore, the best
option for high-risk populations is prevention. Recently, many preventive cancer vaccines …

Nanoparticles (NPs)-based vaccine delivery systems are widely used for their ability to
control the release of antigens and promote immune responses against cancer or infectious …

The peptide‐based therapeutic cancer vaccines have attracted enormous attention in recent
years as one of the effective treatments of tumour immunotherapy. Most of peptide‐based …

Cancer remains one of the global leading causes of death and various vaccines have been
developed over the years against it, including cell-based, nucleic acid-based, and viral …